Volume 33 Number 25 December 18 - January 8, 2015
Ethics, Policy and Law
Toward a functional definition of a "rare disease" for regulatory authorities and funding agencies
Clarke JT, et al. Value Health 2014 Dec;17(8):757-61
Clarke JT, et al. Value Health 2014 Dec;17(8):757-61
Ensuring quality in genomic medicine: Amid the rise in complex laboratory-developed tests, regulatory officials are seeking the right balance on quality assurance
Nelson B Cancer Cytopathol. 2014 Dec;122(12):855-6.
Nelson B Cancer Cytopathol. 2014 Dec;122(12):855-6.
Ethical perspectives on translational pharmacogenetic research involving children
Madadi P Paediatr Drugs 2014 Dec
Madadi P Paediatr Drugs 2014 Dec
Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature
Otten E, et al. Genet Med 2014 Dec
Otten E, et al. Genet Med 2014 Dec
Regulating genetic information--exploring the options in legal theory
Eur J Health Law 2014 Dec;21(5):425-53
Eur J Health Law 2014 Dec;21(5):425-53
Researchers' views on informed consent for return of secondary results in genomic research
Appelbaum PS, et al. Genet Med 2014 Dec
Appelbaum PS, et al. Genet Med 2014 Dec
What are some of the ELSI challenges of international collaborations involving biobanks, global sample collection, and genomic data sharing and how should they be addressed?
Dove ES, et al. Biopreserv Biobank 2014 Dec;12(6):363-4
Dove ES, et al. Biopreserv Biobank 2014 Dec;12(6):363-4
No hay comentarios:
Publicar un comentario